Seroba Kernel
Press Archives
2009 Press Releases
2008 Press Releases
2007 Press Releases
2006 Press Releases
2005 Press Releases
2004 Press Releases
2002 Press Releases

2008 Press
11th November
Alimentary Health Ltd. Announces Licensing Agreement with P&G Pet Care.
5th November
Merrion Pharma signs License Agreement with Nova Nordisk up to US$58m
4th November
Merrion Pharma receives prestigious Frost & Sullivan Award
29th September
Merrion Pharma moves to next stage of drug research programme with Nova Nordisk
18th July
AGI announces agreement with FDA on key aspects of Rezular™ ARDIS Phase III programme
21st May
AGI Therapeutics reports key pharmacological and clinical findings for Rezular™ presented at DDW in San Diego
15th May
Opsona Therapeutics Ltd Receives Milestone Payments Under Wyeth Collaboration
14th May
Alimentary Health Ltd. receives orphan-drug designation for the treatment of pediatric ulcerative colitis
2nd April
AGI announces key findings of clinical PK study of arbaclofen (AGI-006)
17th March
AGI Therapeutics announces completion of the optimisation phase of development of AGI-010
21st February
Clinical study supports the pharmacokinetic and safety profile of Rezular™
5th February
BIOSENSIA COMPLETES A €2 MILLION FUNDING ROUND
5th February
AGI announces first patient dosed in Phase II trial of AGI-004 in chemotherapy-induced diarrhoea
27th January
Labcyte and Deerac Fluidics Combine Forces to Enhance Low Volume Liquid Handling
21st January
Alimentary Health Enters into Research and Development Agreement with ConvaTec
Alimentary Health Ltd. Announces Licensing Agreement with P&G Pet Care.


Alimentary Health Expands the Use of Probiotics to Companion Animals

Cork, Ireland, November 11, 2008: Alimentary Health Ltd. ("Alimentary Health" or "the Company"), the development stage specialty biotechnology company, today announces that it has signed a worldwide licensing agreement with P&G Pet Care (NYSE: PG), makers of two of the worlds leading companion animal pet care products, Iams and Eukanuba.

Under the licensing agreement, Alimentary Health’s and P&G´s proprietary pet care probiotics will be used in P&G Pet Care´s nutritional supplement products. The global market for companion animal pet care products was estimated to be over $40 billion in 2007. Alimentary Health will receive an undisclosed royalty on sales of all products containing the pet care probiotics.

In 2001, Alimentary Health partnered with P&G to develop safe and effective probiotic products for gastrointestinal (GI) indications. In 2007, P&G Health Care started using Alimentary Health’s natural probiotic strain Bifidobacterium Infantis 35624 (Bifantis®), in Align® in the US. Align® is a daily probiotic supplement that helps build and maintain a strong and healthy digestive system.

Barry Kiely, CEO of Alimentary Health commented "Today’s announcement comes as a result of our continued successful collaboration with P&G. We are please that our ongoing efforts have once again resulted in Alimentary Health’s technology making it to the marketplace. This agreement is a result of a successful research and development program between the two companies and it brings us closer to fulfilling our vision of becoming the worldwide leader in the research, discovery and clinical development of probiotics. We are proud of our long standing association with such a leading multi-national company."

"P&G Pet Care is excited about the opportunity to commercialize our work with Alimentary Health and continue our collaboration with such a knowledgeable company in the research of probiotics," said Dan Rajczak, General Manager and Vice President of P&G Pet Care.


About Alimentary Health

Alimentary Health is a development stage specialty biotechnology company located in Ireland. The company is focused on the discovery, development and commercialization of proprietary probiotic and pharmabiotic treatments for gastrointestinal disorders and other inflammatory conditions. Alimentary Health is the foundation industry partner of the Alimentary Pharmabiotic Center based at University College Cork, Ireland.
www.alimentaryhealth.ie


About P&G Pet Care

For more than 60 years, P&G Pet Care (NYSE:PG), the maker of Iams and Eukanuba, has enhanced the well-being of dogs and cats by providing world-class quality foods and pet-care products. To learn more about Eukanuba ® and Iams ® Dog & Cat Foods or general pet care and nutrition information, call the Iams Consumer Care Center at (800) 446-3075. You can also visit us on the Web at www.iams.com or www.eukanuba.com


About Procter & Gamble

Three billion times a day, P&G brands touch the lives of people around the world. The company has one of the strongest portfolios of trusted, quality, leadership brands, including Pampers®, Tide®, Ariel®, Always®, Whisper®, Pantene®, Mach3®, Bounty®, Dawn®, Gain®, Pringles®, Folgers®, Charmin®, Downy®, Lenor®, Iams®, Crest®, Oral-B®, Actonel®, Duracell®, Olay®, Head & Shoulders®, Wella®, Gillette®, and Braun®. The P&G community consists of 138,000 employees working in over 80 countries worldwide.
Please visit www.pg.com or the latest news and in-depth information about P&G and its brands.


About Bifantis® and Align®

Bifantis® (Bifidobacterium infantis 35624) is a natural probiotic strain. Clinical trials have demonstrated that regular use of Bifantis helps to build and maintain a strong, healthy digestive system. Capsules of Bifantis deliver millions of good bacteria to work within the digestive system to restore intestinal balance and maintain normal digestive health. For more information, visit www.bifantis.com

Align® is a daily probiotic supplement that helps build and maintain a strong and healthy digestive system. Align works by providing a natural defense against episodic digestive upsets such as constipation, diarrhea, abdominal discomfort, urgency, gas, and bloating. Align is the only probiotic supplement containing Bifantis, an FDA-approved NDI. Align is sold in boxed blister packs of 28 easy-to-swallow capsules. The 28-day supply retails for approximately $32.99. For more information, visit www.aligngi.com.